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 The aim of this study is to investigate the impact of plasmodium 
falciparum infection in parturient women in Central Sudan where malaria 
transmission is mesoendemic. The purpose of this paper is to find out the 
prevalenceof malaria parasitemia and the risk of anemia among parturient women 
and to suggest appropriate strategies to lower their prevalence rates.  
Methods: 
 This prospective study was conducted at Medani Teaching Hospital, Sudan 
a tertiary regional referral center, during the period January 1997 through to 
December 1997. All cases were admitted during labor to the delivery room and 
were clinically suspected to have malaria. History, examination and investigations 
were carried out on all patients.  
Results:  
The total number of patients enrolled in this study was 550, amounting to 
14.9% of all women (N=3,687) who delivered during the study period. The 
prevalence of malaria parasitemia was 58.9% (N=550) while prevalence of anemia 
(defined as hemoglobulin   ….9.0 g/dl) was 24.1% the mean hemoglobuin levels 
in patients with positive and negative malaria parasitemia was 9.72+ 1.62 and 
9.85+ 1.60 g/dl. Statistically the difference in the mean hemoglobulin level was 
not significant, t=0.879, A significant negative correlation between parasite count 
in maternal blood and hemoglobulin level of the mother, was observed, where 
r=0.121 (P=0.032). out of 17 (3.3%) patients who had used chloroquine tablets for 
prophylaxis, 11patients still had positive parasitemia. Although there was a higher 
parasite count in those 11 patients, statistically the difference was not significance 
where P< 0.05.  
Conclusion:  
The study documents a high prevalence of malaria parasitemia and anemia 
among the parturient women in Central Sudan. There were 533 pregnant women 
(97%) who did not use chloroquine tablets as chemoprophylaxis and 17 (3%) had 
prophylaxis. Eleven of the later (N=17) had positive parasitemia. In view of the 
high prevalence of parasitemia and anemia, and although the sample of patient 
who used chloroquine tablets for prophylaxis and had positive parasitemia is small 
(17 out of 550), a wid scale prophylaxis placebo- controlled trial is recommended 
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to test the impact of prophylaxis during pregnancy and to measure the effect on the 
mother, and the neonate. The drug that proves to be effective as a prophylactic, 
should be an integral part of ante-natal care along with iron and folic acid as anti-
anemic therapy. Moreover, prompt treatment of malaria infection with the 
appropriate anti-malaria drug, spray of insecticides and the use of insecticide- 





Introduction.  Malaria remains one of the most wide spread parasite in the 
world .1It is a serious problem particularly in Africa, south of the sahara, 
where approximately 90% of clinical cases occur. Either alone or in 
combination with other diseases, it is estimated to kill between1.1 and 2.7 
million people worldwide year .2 Malaria was reported to be one of the most 
frequent infectious diseases in sub sahara Africa where 300-500 million 
episodes of clinical malaria cases were treated annually with over one 
million deaths3. 3Pregnant women constitute an important high risk group for 
malaria infection which may cause abortions, stillbirths, intra-uterine growth 
retardation (IUGR) and preterm labor. The mortality rate was significantly 
high in pregnant females in comparison to non-pregnant females4. Human 
infection by plasmodium faciparum (P. falciparum)species is associated with 
a reduction in hemoglobin levels, frequently  leading to anemia. Severe 
anemia in pregnancy was found to be an important contributor to maternal 
and perinatal morbidity and mortality.5-7 In sub-sahara Africa, severe anemia 
in pregnancy is very common, the main causes being iron and folate 
deficiency, malaria, hookworm infestation and advanced human immuno-
deficiency virus (HIV) infection.6 A syndrome of acute hemolysis of anemia 
especially in mid-pregnancy in women with spleenomegally had been 
described in Africa, and it responds to antimalarial drugs and prednisolone. 
8.9 Previous hospital case-control and community follow-up studies,were 
conducted in the same region of central Sudan and showed that there was a 
significant association between low birth weight and malaria during 
pregnancy. 10 Another study, in the area, showed  also association between 
increased risk of neonatal mortality and maternal malaria.11 The aim of this 
study is to investigate the impact of P. Falciparum infection on parturient 
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women in a mesoendemic area in Central Sudan. The maternal and fetal 
morbidity and mortality, the placental and maternal parasitemia and their 
effect on fetal weight, and the common hematological changes in those 
patients are going to be discussed in other papers. The purpose of this paper 
is to find the prevalence of malaria parasitemia and the risk of anemia 
among those parturient women and to suggest recommendations to lower the 
prevalence rate.  
 
Methods. This is a prospective study on Sudanese pregnant women to 
investigate the prevalence and effect of P. falciparum infection in parturient 
women in peri-urban and urban locations carried out during the period 
January 1997 through to December 1997. The study was carried out in 
Central Sudan where malaria transmission is low to moderate 
(Mesoendemic). Malaria transmission in this region is described as perennial 
with P. falciparum accounting for over 90% of the cases. 12 The  region is 
famous for its agricultural scheme where water borne diseases are very 
common especially malaria and bilharzia. 12 The women included in this 
study, were those who presented to the labor room in labor at Medani 
Teaching Hospital (MTH), Sudan, and were clinically suspected to have 
malaria. They had 2 or more of the clinical presentations of fever, rigors, 
headache, vomiting, diarrhea, abdominal and joint pains. The diagnosis of 
malaria was only made if the patient was found to have a positive blood film 
for malaria parasite. An informed consent was given by all patients. A form 
containing a detailed medical history was filled up by the attending 
physician (aresident or a registrar). The form contained the name of the 
patient, age, locality, level of education, gravidity, parity, number of 
miscarriages, gestational age in weeks, number of attacks of malaria during 
that pregnancy, the use of chloroquine phosphate tablets as prophylaxis (2 
tables weekly, each tablet contains 600 mg chloroquine phosphate base), and 
whether taking iron and folate or not. Then all patients underwent a physical 
examination. Peripheral blood samples were obtained and sent for thin and 
thick blood film examination for malaria parasite. Then venous blood 
sample was drawn from those who have positive blood film for parasite 
count. Parasitologic examinations were conducted in Giemsa – stained slides 
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prepared from maternal blood at the Gezira University Reference laboratory 
in Wad Medani, Sudan. A team of trained  technicians examined 100 
microscopic field on each slide to determine parasite species and counts. All 
slides were reviewed by traned technician  to confirm the diagnosis. For all 
patients, a complete blood count was carried out. The hemoglobulin (Hb) 
was determined by the acid hematin method (Sahli) described by Baker and 
Silverton.13 All laboratory investigations were conducted under close 
supervision of a pathologist. The data was computed and analyzed using 
statistical package for social sciences (SPSS) for windows. Students t test 
and chi- square were used as test of significance at 5% level of significance. 
A simple correlation coefficient ( r) was used to study the correlation 
between quantitatives variables.  
 
Results. The total number of patient enrolled in the study was 550 parturient 
women (14.9%) of all women number (N)=3687 who delivered during the 
study period. Their ages ranged from 14 to 42 years with a mean age of 
30.03 + 6.96 years. The parity ranged from one to 9 with a mean parity of 
3.43 +  1.94. The prevalence of malaria parasitemia among the parturient 
women examined, was 58.9% (N=550). The prevalence of anemia (defined 
as Hb less than 9.0 g/dI) was 24.1%. The overall Hb levels ranged from 2.3 
to 14.4 g/dI with a mean Hb level of 9.77 + 1.61 g/dI. 
 
 
Maternal parasitemia and hemoglobulin level (Table1.) The mean Hb level 
in patients with positive malaria parasitemia was 9.72 + 1.62 g/dI and the 
mean Hb level in patients with negative malaria parasitemia was 9.85 +  
1.60 g/dI. Statistically the difference in the mean Hb level was not 
significant t=0.879,(p< 0.05). though there was no difference in Hb levels 
between patients who had parasitemia and patient who had not, there was 
significant negative correlation between parasite count in maternal blood and 
Hb level of the mother, there r=0.211 (p=0.032).  
 
    Table1 –Maternal parasitemia and hemoglobulin level.  
Mother parasitemia N of patients Man hemoglobulin level (SD) 
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N –number, SD- standard deviation,t-0879,(p< 0.05) 
 
Mother parasitemia and parity (Table 2). Out of the 146 primigravida, 82 
(56.2%) had parasitemia, 179 (57.7%) of the multiparous patients (2-5) 
(N=310) had positive parasite and 63 (67%) of the grandmultipara (6+) 
(N=94) had parasitemia. There was no statistically significant difference 
between the presence of parasitemia in primigravidae and other parities. 
X2=3.182 (p< 0.05).  
Parasite counts in patients who had prophylaxis and those did not. Seventeen 
patients (3.3%) (N=550) used chloroquine tablets as prophylaxis. Out of 
those 17,11 had positive oarasitemia (68%). The mean parasite count among 
those 11 patients was 108.64 + 183.59 and 66.88 +  132.80 in those who had 
no prophylaxis (N=313).Although there were more parasite count in those 
11, patients, statistically the difference was not significant where p< 0.05.  
 
     Table 2- Mother parasitemia and parity. 
 
Parasitemia 






















Total  146(100) 310 (100) 94 (100) 550 
(100) 
N – number,-ve-negative,+ve-positive,x2-3.183,p-0.05 
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Discussion. Malaria infection in humans by P. falciparum species is 
associated with a reduction in Hb levels, frequently leading to anemia. 
Plasmodium falciparum  causes the most severe and profound anemia with 
significant risk of death. 5 The potential maternal and neonatal morbidity and 
mortality due to malaria infection have generated a lot of concern among 
practising clinicians.2-6 Analysis of data from a malaria clinic in Central 
India, showed a high malaria prevalence among pregnant women to non- 
pregnant women.14 The same study showed that malara infection was more 
frequent in primigravidae falling progressively with increasing parity. 
Severe anemia, hepatic and renal failure, again were observed more 
commonly in pregnant females (20%) in comparison to non-pregnant 
females (4.1%) suffering from P.falciparum. 4 In Sub –Sahara Africa, severe 
anemia in pregnancy is very common and it is an important contributor to 
maternal and perinatal morbidity and mortality. The  main causes of anemia 
being iron and folate deficiency, malaria hookworm infestation and 
advanced HIV infection. 6 Previous studies in the Sudan showed that P. 
Ffalciparum, represents the main malaria parasite species in the country. 15.16 
Surveys carried out in the Gezira (central Sudan) showed that P. falciparum 
remaining the dominant species and P. ovale was not reported17 . This study 
which is carried out in Central Sudan showed a prevalence of 58.9% 
(N=550) of P. falciparum malaria parasitemia among the parturient women 
examined and a prevalence of 24% of anemia. There was no statistical 
significant difference in mean Hb level between patients with positive and 
negative malaria parasitemia where t=0.879,(p=< 0.05). A similar study 
carried out in Tanzania, showed a lower prevalence of malaria parasitemia 
among pregnant women examined,9.4% (N=705) and lower prevalence of 
anemia (defined as hemoglobulin (Hb)> 8.5 g/dI), of 12.4% (N=579). They 
also observed that there was no significant difference in prevalence 
proportions of malaria parasitemia in relation to age and parity.18 However 
the prevalence of anemia among women of the age group 31-45 years was 
significantly lower than that observed among women in the age group 14-20. 
Another study carried out in Malawi for malaria and anemia in antenatal 
women showed a similar prevalence of parasitemia and anemia to the 
findings of this study. They found 42.7% (N=4762) had a malaria 
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parasitemia which was more common and of higher densities in 
primigravidae and teenagers than multigravidae or older women. 19 Also, 
they showed that 57.2% of the women were anemic and women with 
moderate or severe anemia (7.0-8.9 g/dI), (> 7.0 g/dI), had higer parasite 
prevalence and densities than women with mild/no malaria. A similar trend 
was observed in this study, where there was a significant negative 
correlation between parasite count in maternal blood and Hb level of the 
mother, r=0.121 (p=0.032). In other words with an increase in parasite count 
in the maternal blood, there was an associated decrease in Hb level in the 
mother. It was also found that the Hb level of the patient in relationship to 
parity was statistically different (f=4.629;p=0.01). when further statistical 
analysis using Schiffe test was carried out, it was found that the mean Hb 
levels of the primigravidae was significantly higher than the multiparous (2-
5) and grandmultiparous (6+). These finding are not in agreement with other 
findings, which indicated that parasitemia and anemia are more common in 
primigravidae than multiparous. Mockenhaupt et al 20 showed in their study 
that with increasing gravidity, p.falciparum infection rates and parasite 
densities decreased and the corresponding anemia, fever and evidence of 
inflammation were more frequent in primigravidae than in 
multigravidae.14The primigravida in this study had higher Hb levels than the 
multiparous patient. This could be explained by the fact that the anemia is 
usually more common in multifarious patients. 21 Though malaria as a cause 
of anemia is preventable, the overall prevalence of anemia and parasitemia 
has not changed over many years. 5 This is probably due to several reasons 
including. operational problems and inadequate intervention measures. In 
Central Sudan the problem of malaria is most acute in pregnant women 
where malaria transmission is mesoendemic. In recent years malaria 
transmission has been influenced by amount of rain, population movements, 
extension of agricultural and irrigation projects, the spread of resistance to 
insecticide and the deterioration of health infrastructure. On the other hand, 
P. falciparum is increasing worldwide due to an increase of development of 
resistance to the available antimalarials. All these factors aggravate the 
situation of malaria in pregnant women, and the options for their treatment, 
are even more restrictive due to the unknown effects of anti malaria on the 
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fetus. Chemoprophylaxis using chloroquine was claimed to be effective in 
reducing peripheral malaria parasitemia.22 Ndyomugyenyi et al 23 in Western 
Uganda, found that chloroquine prophylaxis and iron and folic acid 
supplementation significantly increased Hb levels during pregnancy as 
compared to case management. In this study 533 patients (97%) did not use 
chloroquine as prophylaxis, and out of those who used chloroquine 
prophylaxis 17 (3%),11 had positive parasitemia. Whether this was due to 
chloroqine resistant is not clear, due to the small number of cases.  
It is obvious from the above results that the prevalence of malaria 
parasitemia and anemia were high in Central Sudan, The patients who used 
chloroquine for prophylaxis are few (3%). These findings suggest the need 
for intervention measures that should be directed at controlling malaria in 
pregnancy, which is a major public health problem. Improved control of 
such disease requires better integration into the health care system. Given 
the costs and inputs required to effectively deliver a wide scale prophylaxis 
program, we testing the impact of prophylactic drugs given during 
pregnancy, to see the outcome on mother and neonatal is warranted. Then 
the drug that proves to be effective as a prophylactic should be an integral 
part of ante-natal care along with iron and folic acid as anti-anemic therapy. 
Prompt treatment of malaria infection with the appropriate anti-malarial 
drugs, and other general control measures, such as insecticide spraying, use 
of insecticide impregnated bed nets and curtains for preventing malaria are 
also recommended.  
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